<DOC>
	<DOCNO>NCT01092663</DOCNO>
	<brief_summary>This study assess effect colesevelam , alone combination sitagliptin , glucose metabolism subject T2DM inadequately control diet exercise</brief_summary>
	<brief_title>The Effects Co-admin Colesevelam Sitagliptin Glucose Metabolism Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>The hypothesis co-administrationof colesevelam plus sitagliptin result great reduction HbA1c compare colesevelam HCl treatment 1. improve effect colesevelam fast glucose metabolism 2. improve effect colsevelam postprandial glucose metabolism</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Male Female Females childbearing potential approved birth control method Negative pregnancy test female childbearing potential Previously diagnose newly diagnose T2DM drug naïve subject HbA1c : 6.710 % Age 18 80 year BMI ≥ 18.5 kg/m2 ≤ 40 kg/m2 Fasting serum glucose &lt; 300 mg/dL Normal liver function , normal thyroid function , history liver , biliary intestinal disease Normal TSH On stable diet exercise routine least 4 week prior screen Has stable weight ( +/5 % ) ≥3 month screen A history type 1 diabetes mellitus history diabetic ketoacidosis History chronic ( require daily &gt; 2 month ) use insulin therapy Treatment blood pressure lower therapy stable three month screen Treatment lipid lower medication statin Treatment statins stable three month screen Treatment DPP4 inhibitor GLP1 agonists time Treatment thiazolidinedione ( TZD ) within last 6 month screen History allergic toxic reaction sitagliptin colesevelam History dysphagia , swallow disorder , bowel obstruction , intestinal motility disorder , gastrointestinal disorder History major gastrointestinal surgery History kidney problem Fasting plasma triglyceride &gt; 300 mg/dL Serum LDLC &lt; 60 mg/dL Positive toxicology test Known hypersensitivity colesevelam HCl sitagliptin . Any contraindication study medication ( colesevelam HCl sitagliptin ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Colesevelam</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>sitagliptin</keyword>
	<keyword>glucose metabolism</keyword>
</DOC>